Category: CNS/Neurology
Global CNS/Neurology
-
Medical Marijuana Market by Route of Administration (Inhalation, Oral, Topical), Application (Anorexia, Arthritis, Migraine), Distribution Channel - Global Forecast 2024-2030
... to reach USD 15.66 billion in 2024, at a CAGR 9.07% to reach USD 26.16 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Medical Marijuana Market. It offers ... Read More
-
Brain Health Supplements Market by Type (Natural Molecules, Synthetic Molecules, Vitamin & Minerals), Form (Capsules & Tablets, Powder, Softgels), Function, Distribution Channel - Global Forecast 2024-2030
... USD 9.22 billion in 2023 and expected to reach USD 10.07 billion in 2024, at a CAGR 9.64% to reach USD 17.58 billion by 2030. Global Brain Health Supplements Market FPNV Positioning Matrix The FPNV ... Read More
-
Cardiac Biomarker Market by Type (Brain Natriuretic Peptide or NT-proBNP, Creatine Kinase, Ischemia Modified Albumin), Location of Testing (Laboratory Testing, Point of Care Testing), Application - Global Forecast 2024-2030
... estimated at USD 4.62 billion in 2023 and expected to reach USD 5.31 billion in 2024, at a CAGR 14.90% to reach USD 12.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Pain Management Devices Market by Product (Analgesic Infusion Pumps, Electrical Stimulators, Neurostimulation), Application (Cancer, Facial & migraine, Musculoskeletal disorder), End-user - Global Forecast 2024-2030
... in 2023 and expected to reach USD 2.87 billion in 2024, at a CAGR 8.45% to reach USD 4.70 billion by 2030. Global Paint Driers MarketPaint driers, also known as drying agents or catalysts, are ... Read More
-
Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Global Forecast 2024-2030
... expected to reach USD 1,026.86 million in 2024, at a CAGR 8.74% to reach USD 1,705.58 million by 2030. Global Postpartum Depression Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Dementia Drugs Market by Indications (Alzheimer's Disease, Lewy Body Dementia, Parkinsons Disease Dementia), Drug Class (Cholinesterase Inhibitors, Glutamate Inhibitors, MAO Inhibitors) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 10.78 billion in 2024, at a CAGR 10.39% to reach USD 19.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Neuromodulation Devices Market by Product (Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators), Application (Neurological Disorders, Pain Management, Respiratory Disorders), End User - Global Forecast 2024-2030
... USD 8.66 billion in 2023 and expected to reach USD 9.79 billion in 2024, at a CAGR 13.54% to reach USD 21.07 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Neurorehabilitation Devices Market by Products (Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators), Therapy Area (Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.42 billion in 2024, at a CAGR 7.62% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Brain Imaging Modalities Market by Imaging Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET)), Patient Type (Adults & Paediatrics, Infants), End User - Global Forecast 2024-2030
... size was estimated at USD 14.87 billion in 2023 and expected to reach USD 16.05 billion in 2024, at a CAGR 7.66% to reach USD 24.94 billion by 2030. Global Brain Imaging Modalities Market FPNV ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030
... USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Neurology Endoscopy Devices Market by Product (Accessories, Endoscopes, Operative Devices), Indication (Alzheimer’s Disorders, Brain Cancer, Brain Tumor), Usability, End User, Application - Global Forecast 2024-2030
... 5.19 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.22% to reach USD 8.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Transcatheter Devices Market by Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Repair Devices, Transcatheter Replacement Devices), Application (Cardiovascular, Neurology, Oncology) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 15.97 billion in 2024, at a CAGR 13.70% to reach USD 34.56 billion by 2030. Global Transcatheter Devices Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030
... to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Diaphragm Pacing Therapy System Market by Product (Diaphragm Pacemaker, External Diaphragm Pacemaker), Application (Amyotrophic Lateral Sclerosis, Spinal Cord Injury) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 5.40 billion in 2024, at a CAGR 7.39% to reach USD 8.29 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market by Treatment (Medication, Stem Cell Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... 2023 and expected to reach USD 790.52 million in 2024, at a CAGR 7.73% to reach USD 1,237.05 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Amyotrophic Lateral ... Read More
-
Interventional Neurology Devices Market by Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices), End-User (Ambulatory Care Centers, Hospitals, Neurology Clinics) - Global Forecast 2024-2030
... estimated at USD 2.02 billion in 2023 and expected to reach USD 2.17 billion in 2024, at a CAGR 8.97% to reach USD 3.69 billion by 2030. Global Interventional Neurology Devices Market FPNV Positioning Matrix ... Read More
-
Neurology Devices Market by Product (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurostimulation Devices), End User (Ambulatory Surgery Centers, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.10 billion in 2024, at a CAGR 7.81% to reach USD 16.03 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurology ... Read More
-
Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2024-2030
... was estimated at USD 1.16 billion in 2023 and expected to reach USD 1.27 billion in 2024, at a CAGR 9.63% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030. Global Brain Biomarkers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Pediatric Imaging Market by Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), Application (Cardiology, Gastroenterology, Neurology), End-User - Global Forecast 2024-2030
... expected to reach USD 38.57 billion in 2024, at a CAGR 8.43% to reach USD 62.77 billion by 2030. Global Pediatric Medical Device Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Anxiety Drugs Market by Type (Generic Drugs, Patent Medicine), Application (Help Sleep, Treat Anxiety, Treat Premature Ejaculation) - Global Forecast 2024-2030
... expected to reach USD 19.03 billion in 2024, at a CAGR 8.78% to reach USD 31.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anxiety Drugs Market. It ... Read More
-
Neuroprotection Market by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists), Treatment (Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.20 billion in 2024, at a CAGR 9.86% to reach USD 28.52 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neuroprotection Market. ... Read More
Research Assistance
